A major international review led by the University of Dundee’s Professor Peter Davey has identified effective and safe ways to reduce unnecessary use of antibiotics in hospitals.
The updated Cochrane Review published today concludes that guidelines and policies to pinpoint the patients in need of antibiotics have the greatest impact when doctors are supported to change their prescribing behaviour.
Antibiotics are used to treat bacterial infections, such as pneumonia, but antibiotic resistance has become a major public health problem with some infections no longer treatable using currently available drugs.
Infections caused by antibiotic-resistant bacteria lead to longer hospital stays and carry a higher risk of death. Inappropriate use of antibiotics is associated with increased resistance, and studies have shown that about half of the time physicians in hospital are not prescribing antibiotics appropriately.
A team of Cochrane researchers from the UK assessed the effectiveness and safety of interventions to improve how physicians prescribe antibiotics to hospital inpatients. They also wanted to know how much variation there was among the different types of interventions they studied.
Lead author Professor Davey, from the Division of Population Health Sciences at Dundee, said, “This Cochrane Review shows that a wide variety of different interventions have been successful in safely reducing unnecessary antibiotic use in hospitals.
“We do not need more studies to answer the question of whether these interventions reduce unnecessary antibiotic use, but we do need more research to understand why the most effective behaviour change techniques are not more widely adopted within hospital settings.
“Future research should instead focus on targeting treatment and assessing other measures of patient safety, and different interventions that explore the barriers and facilitators to implementation. Appropriate antibiotic use in hospitals should ensure effective treatment of patients with infection and reduce unnecessary prescriptions. Successful adoption of the interventions we have studied could have considerable impact on health service, policy, and future decision-making for patients.”
The researchers analysed 221 studies from the US, Europe, Asia, South America, and Australia. The interventions were aimed at healthcare professionals who prescribe antibiotics to hospital in-patients receiving acute care and those undergoing planned surgery.
The interventions broadly fell into two categories. ‘Restrictive’ techniques applied rules to make physicians prescribe properly, whilst ‘enabling’ techniques provide advice or feedback to help physicians make more informed prescribing decisions. In both cases, the aim was to increase the number of appropriate prescribing decisions so that patients who were unlikely to benefit from antibiotics did not get them, whilst they were still used for patients who stood to benefit from them.
The researchers found high-quality evidence that, following either type of intervention, 58% of hospital in-patients received treatment in line with prescribing guidelines, compared with 43% of the patients in the standard practice groups. The interventions shorten the duration of antibiotic use from 11 days to 9 per patient, and probably reduce hospital stay from an average of 13 days to 12 per patient.
Data showed that the risk of death was 11% in both treatment groups, suggesting that reducing antibiotic use did not lead to an increase in harm. Further studies provided only limited evidence of an association between adopting the interventions and a reduction in hospital infections.
Interventions that included enabling or restrictive techniques were consistently more effective than interventions that relied on simple education alone (e.g. meetings or distribution of guidelines). Moreover, adding enabling techniques increased the effectiveness of restrictive techniques. However, only 10% of interventions used the most effective enabling techniques such as goal-setting, feedback, and action planning.
This research was supported by grants from the Chief Scientist Office, Scottish Government and the British Society for Antimicrobial Chemotherapy.
Notes to editors:
Cochrane is a global independent network of researchers, professionals, patients, carers, and people interested in health.
Cochrane produces reviews which study all of the best available evidence generated through research and make it easier to inform decisions about health. These are called systematic reviews.
Cochrane is a not-for-profit organization with collaborators from more than 130 countries working together to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest. Our work is recognized as representing an international gold standard for high quality, trusted information.
Find out more at cochrane.org
For media enquiries contact:
University of Dundee
Nethergate, Dundee, DD1 4HN
Tel: +44 (0)1382 384768
Mobile: 07854 953277